Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Interventional, prospective, single-centre study aimed to evaluate the impact of a video-assisted remote speech therapy consultation in relation to the complexity and specificity of the care of patients with ORL cancer. Three indications will be studied: phonation problems, swallowing problems and other problems.
The study will be conducted on a population of patients with T3, T4 ORL cancer requiring speech therapy.
Each patient included will have a video-assisted speech therapy consultation with a private speech therapist and an expert speech therapist. At the end of this video consultation, the patient and the private speech therapist will be asked to complete a satisfaction questionnaire.
At the follow-up visit following the video-assisted consultation, the patient will have completed participation in the study.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patient with T3-T4 ORL cancer, relevant to surgery and/or radiotherapy and/or chemotherapy. | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Patient managed at the IUCT-O and by a private speech therapist (near the patient's home). | Other | Each patient included will have a video-assisted remote speech therapy consultation with a private speech therapist (near the patient's home) and the expert speech therapist of IUCT-O center. At the end of this video consultation, the patient and the private speech therapist will be asked to complete a satisfaction questionnaire. |
| Measure | Description | Time Frame |
|---|---|---|
| The rate of patients for whom tele-therapy will be considered successful. | 12 months for each patient |
| Measure | Description | Time Frame |
|---|---|---|
| The rate of patients with full or partial resolution of speech-language pathology at the end of the telecare consultation. | 12 months for each patient |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jérôme SARINI | Contact | 05 31 15 60 16 | sarini.jerome@iuct-oncopole.fr | |
| Jean-Claude FARENC | Contact | 05 31 15 51 97 | farenc.jean-claude@iuct-oncopole.fr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Institut Universitaire du Cancer de Toulouse - Oncopole | Recruiting | Toulouse | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|